» Articles » PMID: 21991467

Clinical and Surgical Management of an Aggressive Cherubism Treated with Autogenous Bone Graft and Calcitonin

Overview
Journal ISRN Dent
Specialty Dentistry
Date 2011 Oct 13
PMID 21991467
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Cherubism is a rare autosomal-dominant inherited syndrome and is usually self-limiting; it starts in early childhood and involutes by puberty. It is a benign fibroosseous disease, characterized by excessive bone degradation of the upper and lower jaws followed by development of fibrous tissue masses. The purpose of this clinical report is to describe a rare and aggressive form of cherubism on an adult female patient that has been treated in our Bioscience Center for Special Health Care Needs-CEBAPE. The patient was firstly submitted to the surgical procedure with partial curettage of the lesion, and the cavity was filled with autogenous cancellous bone and bone marrow grafts. Furthermore, the support treatment used was the administration of salmon calcitonin by nasal spray during the first year after the preconized procedure. At 4-year followup, we confirmed the stomatognathic system improvement and esthetic rehabilitation, which led to a significant increase in the patient's quality of life.

Citing Articles

Impact of Multimodal Rehabilitation Protocol in a 20-Year-Old Patient With Cherubism Undergone Facial Surgery: A Rare Case Report.

Sheikh S, Athawale V, Fating T Cureus. 2024; 16(3):e56191.

PMID: 38618375 PMC: 11015988. DOI: 10.7759/cureus.56191.


Surgical management of mandibular cherubism in an adolescent: integration of virtual surgical planning.

Ladnier E, Sheth A, Shupak R BMJ Case Rep. 2023; 16(9).

PMID: 37669824 PMC: 10481715. DOI: 10.1136/bcr-2023-255059.


Pharmacological management of cherubism: A systematic review.

Cailleaux P, Porporatti A, Cohen-Solal M, Kadlub N, Coudert A Front Endocrinol (Lausanne). 2023; 14:1104025.

PMID: 36998472 PMC: 10044089. DOI: 10.3389/fendo.2023.1104025.


Cherubism in 12 Year Young Female.

Mazhar H, Samudrawar R, Gupta R, Kashyap M Ann Maxillofac Surg. 2019; 8(2):373-376.

PMID: 30693269 PMC: 6327822. DOI: 10.4103/ams.ams_177_17.


Fibrous dysplasia and cherubism.

Bhattacharya S, Mishra R Indian J Plast Surg. 2016; 48(3):236-48.

PMID: 26933277 PMC: 4750256. DOI: 10.4103/0970-0358.173101.


References
1.
de Lange J, Rosenberg A, Van Den Akker H, Koole R, Wirds J, van den Berg H . Treatment of central giant cell granuloma of the jaw with calcitonin. Int J Oral Maxillofac Surg. 1999; 28(5):372-6. DOI: 10.1034/j.1399-0020.1999.285280513.x. View

2.
Gomes M, de Souza Setubal Destro M, de Freitas Banzi E, dos Santos S, Claro F, de Oliveira Nogueira T . Aggressive behaviour of cherubism in a teenager: 4-years of clinical follow-up associated with radiographic and histological features. Dentomaxillofac Radiol. 2005; 34(5):313-8. DOI: 10.1259/dmfr/32866350. View

3.
Katz J, Underhill T . Multilocular radiolucencies. Dent Clin North Am. 1994; 38(1):63-81. View

4.
Lannon D, Earley M . Cherubism and its charlatans. Br J Plast Surg. 2001; 54(8):708-11. DOI: 10.1054/bjps.2001.3701. View

5.
Whitaker S, Singh B . Intraoral giant cell lesions: the peripheral and central forms of these entities. Pract Periodontics Aesthet Dent. 1995; 7(6):41-7; quiz 48. View